TC Biopharm to start phase II/III studies of ImmuniCell in October
Currently focused on skin, renal and lung cancer, the platform has potential to treat all types of cancer tumours as well as viral…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.